BNP Paribas Discount Zert GBERF 2.../ DE000PE2PMH0 /
| 2024-05-14 1:20:30 PM | Chg.-0.580 | Bid1:36:53 PM | Ask1:36:53 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 506.910EUR | -0.11% | 506.850 Bid Size: 500 |
506.950 Ask Size: 500 |
Geberit AG | - - | 2024-06-27 | Call |
GlobeNewswire
1:30 PM
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
1:30 PM
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
1:30 PM
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
1:30 PM
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
1:30 PM
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
1:30 PM
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
1:30 PM
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
1:30 PM
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
1:30 PM
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
GlobeNewswire
1:30 PM
Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
GlobeNewswire
1:30 PM
nCino Announces Timing of its First Quarter Fiscal Year 2025 Financial Results Conference Call
